CYD-2-11 is a selective Bax agonist (Ki = 34.1 nM) that induces apoptosis and exhibits antiproliferative effects against MDA-MB-231 and MCF-7 breast cancer cell lines (IC50 = 3.22 and 3.81 μM, respectively); it inhibits tumor growth in MDA-MB-231 xenograft models and is useful for research in breast and lung cancers.